Browse studies

Find your next paid study

3,222 recruiting studies matching your filters

Evaluating the Physiological and Psychological Impact of Low-Frequency Vibration Therapy: A Longitudinal Randomized Clinical Trial

The goal of this randomized clinical trial is to learn whether a low-frequency "kinetic wellness" mat (a comfortable mat that gently vibrates) can improve stre…

Healthy Adult Male and Female Volunteers

Estimated

~$10 – $750

Actual pay is set by the research site.

Florida International UniversityNCT07221318

Phase 1

An Open-label Parallel Group Pilot Study to Demonstrate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa

This study is to investigate the efficacy of siplizumab in the treatment of Hidradenitis Suppurativa.

Hidradenitis Suppurativa

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Alabama at BirminghamNCT06326476

Phase 1

PNV21-001: A Phase I Study of a Personalized Multi-Peptide Neo-Antigen Vaccine in Breast Cancer, Pre-Treated Nonsmall Cell Lung Cancer and PD1/PD-L1 Inhibitor-Refractory Melanoma

This phase I trial studies the safety of personalized neo-antigen peptide vaccine in treating patients with stage IIIC-IV melanoma, hormone receptor positive H…

Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more

Estimated

Phase 1

A Phase 1/2 Open-label Clinical Study to Evaluate the Safety and Efficacy of Intravesical Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (NMIBC)

The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose…

Non-Muscle Invasive Bladder Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06637423

Observational

The Blank Center CARE Model™: An Anti-Ableist Approach to Treatment

The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and …

StutteringStuttering, AdultStuttering, Childhood+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas at AustinNCT05908123

Phase 1

TLR9 Immunotherapy for Peritoneal Carcinomatosis (TIPC) - Phase 1 Study of the Safety and Efficacy of ACM-CpG Intraperitoneal Injections for Treatment in Patients With Colorectal or Appendiceal Adenocarcinoma Peritoneal Metastases or Malignant Ascites

The goal of this clinical trial is to determine the safety and efficacy of of ACM-CpG for inoperable peritoneal metastases or malignant ascites. The main quest…

Malignant AscitesColorectal AdenocarcinomaPeritoneal (Metastatic) Cancer+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Brown UniversityNCT07658196

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.

Bladder DysfunctionOveractive BladderBPH With Urinary Obstruction

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT05652023

Phase 2

A Multicenter, Adaptive, Phase 2, Randomized, Open-label Study of Irradiated Autologous Cellular Vaccine in Men With High-Risk Prostate Cancer Following Prostatectomy

The goal of this clinical trial is to learn if the vaccine FK-PC101 works to delay or prevent the return of prostate cancer in men who have had surgery to remo…

Prostate Cancer (Adenocarcinoma)Prostate CAProstate Cancers+4 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Cellvax Therapeutics IncNCT06636682

Phase 1

A Multicenter, Open-Label, Phase 1a/b First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-C477 in Patients With Selected Advanced Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of BG-C477 alone and …

Advanced Solid Tumors

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BeOne MedicinesNCT06596473

Phase 2

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa

This is a multicenter, randomized, double-blinded, placebo-controlled clinical study of ORKA-002 in adult participants with moderate-to-severe HS.

Hidradenitis Suppurativa (HS)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Oruka Therapeutics, Inc.NCT07783542

A Multi-national, Multi-centre, Prospective, Single-arm, Observational, Non-interventional Post-authorisation Safety Study to Investigate Long-term Safety of Sogroya® (Somapacitan) in Adults With Growth Hormone Deficiency (AGHD) Under Routine Clinical Practice

In this study, the general long-term safety and effectiveness of Sogroya (somapacitan) in adults with growth hormone deficiency (AGHD) being treated per normal…

Adult Growth Hormone Deficiency

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Novo Nordisk A/SNCT05718570

Phase 1

Feasibility of an Oral 5 Strain Probiotic (PGC) for GI Toxicity Mitigation During Pelvic Radiation

This research is to determine if an oral probiotic, Pendulum Glucose Control (PGC), can be safely given to patients during pelvic radiation therapy (RT). The r…

Radiation Injuries

Estimated

~$150 – $2,700

Actual pay is set by the research site.

University of CincinnatiNCT07231588